Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,459 | 48,514 | 51,614 | 64,371 | 74,866 |
| Marketable Securities | 929 | 287 | 24,675 | N/A | 10,003 |
| Receivables | 945 | 1,698 | 57 | 3,143 | 1,418 |
| TOTAL | $25,138 | $51,454 | $77,187 | $68,468 | $87,527 |
| Non-Current Assets | |||||
| PPE Net | 471 | 795 | 1,499 | 2,112 | 2,108 |
| Other Non-Current Assets | 6,582 | 9,281 | 12,597 | 12,821 | 9,898 |
| TOTAL | $7,053 | $10,076 | $14,096 | $14,933 | $12,006 |
| Total Assets | $32,191 | $61,530 | $91,283 | $83,401 | $99,534 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,333 | 3,963 | 1,963 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,823 | 3,501 | 2,731 | 2,591 | 2,070 |
| Accrued Expenses | 2,908 | 4,137 | 3,554 | 4,620 | 2,787 |
| Other current liabilities | 85 | 2,112 | N/A | 645 | 6,681 |
| TOTAL | $13,689 | $17,081 | $11,548 | $12,788 | $16,316 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 4,202 | 8,035 | N/A | N/A |
| Other Non-Current Liabilities | 1,003 | 3,162 | 6,018 | 5,121 | 4,306 |
| TOTAL | $1,003 | $7,364 | $14,053 | $5,121 | $4,306 |
| Total Liabilities | $14,692 | $24,445 | $25,601 | $17,909 | $20,622 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,819 | 48,643 | 43,168 | 33,011 | 30,457 |
| Common Shares | 62 | 47 | 43 | 32 | 30 |
| Retained earnings | -341,864 | -301,190 | -250,457 | -197,446 | -153,285 |
| Other shareholders' equity | 0 | 0 | -96 | 0 | 7 |
| TOTAL | $17,499 | $37,085 | $65,682 | $65,492 | $78,912 |
| Total Liabilities And Equity | $32,191 | $61,530 | $91,283 | $83,401 | $99,534 |